SelectBIO Biofabrication and Biomanufacturing March 21-22, 2022 Boston brings together researchers from across various disciplines who are involved in the fabrication of functional, engineered tissue constructs and biomanufacturing.
This field is of great interest for generating in vitro physiological and disease models, for target identification and drug screening, and as potential organ replacements amongst other applications.
A multitude of fabrication approaches to generate tissue engineered constructs exist including photopolymerization, 3D-printing, stereolithography, multiphoton lithography as well as self-assembly approaches. While much progress has been made in generating functional tissues using both synthetic and natural materials, increasing throughput and tissue volume has been challenging. This conference will focus on advanced techniques and approaches being used for biofabrication with a focus on potentially scalable technologies that will allow higher throughput manufacturing of functional tissues.
In addition to scientific presentations, this conference features exhibits with companies showcasing their technologies and product offerings into this field.
Co-located and runs concurrently with the Innovations in Microfluidics & Single Cell Analysis 2022 Conference — Full Access to Attendees and Exhibitors for Maximal Networking.
Proof of Covid-19 Vaccination Required in Order to Participate On-Site at this Event. Participants Not Vaccinated for Covid-19 Can Participate Virtually at this Event.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
